Methylphenidate and hypertension.
Prabhuswamy
Mukesh
M
Srinath
Shoba
S
Girimaji
Satish
S
Seshadri
Shekhar
S
D000293:Adolescent; D001289:Attention Deficit Disorder with Hyperactivity / Q000150:complications / Q000188:drug therapy; D019958:Attention Deficit and Disruptive Behavior Disorders / Q000188:drug therapy / Q000523:psychology; D002395:Catecholamines / Q000097:blood; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007194:India; D007859:Learning Disabilities / Q000188:drug therapy / Q000523:psychology; D008774:Methylphenidate / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors
D002395:Catecholamines; D000697:Central Nervous System Stimulants; D008774:Methylphenidate